Efficacy of magneto-laser therapy in the treatment of ureaplasma infection

Abstract

Aim. To study clinical and epidemiological data in males and females with ureaplasma infection and to evaluate efficacy of magneto-laser therapy used as additional treatment of ureaplasma infection.

Methods. 104 patients (94 men and 10 women) with urogenital ureaplasma infection were observed. Patients were divided into two groups: a study group (n=55) that received standard and magneto-laser therapy, and a comparison group (n=49) that received only standard treatment. Polymerase chain reaction was used to investigate samples for Mycoplasma hominis, Ureaplasma parvum and urealyticum, and bacteriological study for Mycoplasma hominis and Ureaplasma spp. was additionally performed with determining their antibiotic susceptibility. Magnetic therapy was conducted with the use of Michelangelo device (Italy) for 10 minutes to small pelvis area for 10 days.

Results. As a result, 78 (82.9%) males were diagnosed with uretritis, 52 (55.3%) with prostatitis, 37 (39.3%) with cystitis. In females monoinfection was more prevalent than in males (50.0% vs 40.4%). Ureaplasmosis predominantly affected subjects aged 20-29 (97.8%) and 30-39 (86.0%) years. In female group, patients aged 20-29 years prevailed, while in a male group - patients aged 30-39 years. In males, the association of Ureaplasma with Mycoplasma hominis (36.1%) prevailed.

Conclusion. Complex treatment of ureaplasma infection of urogenital tract including magneto-laser therapy demonstrated high clinical efficacy and allowed achieving clinical and laboratory cure of ureaplasma infection in 85.4% of cases.

Keywords

magneto-laser therapy / colposcopy / polymerase chain reaction / cytology

References

[1] Prilepskaja V.N., Bykovskaja O.V. Ureaplasma infection in obstetrics and gynecology — a modern view at the problem. Akusherstvo i ginekologiya. 2007; (2): 21–23. (In Russ.)

[2] Прилепская В.Н., Быковская О.В. Уреаплазменная инфекция в акушерстве и гинекологии - современный взгляд на проблему. Акушерство и гинекология. 2007; (2): 21-23.

[3] Perlamutrov Yu.N., Chernova N.I., Savost'yanova N.Yu. Optimization of methods of treatment of urogenital ureaplasmosis in women of reproductive age. Kliicheskaya. dermatologiya i venerologiya. 2006; (3): 84–85. (In Russ.)

[4] Перламутров Ю.Н., Чернова Н.И., Савостьянова Н.Ю. Оптимизация методов лечения урогенитального уреаплазмоза у женщин репродуктивного возраста. Клин. дерматол. и венерол. 2006; (3): 84-85.

[5] Farrell J., Sarson J., Akeson J. et al. Ureaplasma parvum prosthetic joint infection detected by PCR. J. Clin. Microbiol. 2014; 52 (6): 2248–2250. DOI: 10.1128/JCM.00432-14.

[6] Farrell J., Sarson J., Akeson J. et al. Ureaplasma parvum prosthetic joint infection detected by PCR. J. Clin. Microbiol. 2014; 52 (6): 2248-2250. DOI: 10.1128/JCM.00432-14.

[7] Ursula K., Jaanna E., Marek E. et al. Colonization of the lower uregenital tract with U. parvum can cause asymptomatic infection of the upper reproductive system in women: a preliminary study. Arch. Gynecol. Obstet. 2014; 289: 1129–1134. DOI: 10.1007/s00404-013-3102-7.

[8] Ursula K., Jaanna E., Marek E. et al. Colonization of the lower uregenital tract with U. parvum can cause asymptomatic infection of the upper reproductive system in women: a preliminary study. Arch. Gynecol. Obstet. 2014; 289: 1129-1134. DOI: 10.1007/s00404-013-3102-7.

[9] Zagrtdinova R.M., Bogolyubskaya A.L., Dimakova E.V. Optimization of treatment of urogenital mycoplasmal infection in women. Akusherstvo i ginekologiya. 2014; (9): 103–107.

[10] Загртдинова Р.М., Боголюбская А.Л., Димакова Е.В. Оптимизация лечения урогенитальной микоплазменной инфекции у женщин. Акушерство и гинекология. 2014; (9): 103-107.

[11] Shevchenko E.A., Artifeksova A.A. Urogenital infections and chronic inflammatory processes of the reproductive system. Epidemiologiya i infetscionnye bolezni. 2010; (2): 25–27. (In Russ.)

[12] Шевченко Е.А., Артифексова А.А. Урогенитальные инфекции и хронические воспалительные процессы репродуктивной системы. Эпидемиол. и инфекц. бол. 2010; (2): 25-27.

[13] Kisina V.I. Algorithm for diagnosis and treatment of urogenital diseases associated with Ureaplasma spp. Klinicheskaya dermatologiya i venerologiya. 2012; (5): 89–94. (In Russ.)

[14] Кисина В.И. Алгоритм диагностики и лечения урогенитальных заболеваний ассоциированных с Ureaplasma spp. Клин. дерматол. и венерол. 2012; (5): 89-94.

[15] Savicheva A.M., Chkhartishvili M.R., Zolotoverkhaya E.A., Shipitsyna E.V. Efficacy of doxycycline in the treatment of urogenital infections associated with ureaplasmae. Ginekologiya. 2009; 11 (6): 38–41. (In Russ.)

[16] Савичева А.М., Чхартишвили М.Р., Золотоверхая Е.А., Шипицына Е.В. Эффективность доксициклина при лечении урогенитальных инфекций, ассоциированных с уреаплазмами. Гинекология. 2009; 11 (6): 38-41.

[17] Prokhorenkov V.I., Shapran M.V. Ureaplasma infection: the current state of sensitivity and resistance to antibiotics. Vestnik dermatologii i venerologii. 2006; (2): 59–61. (In Russ.)

[18] Прохоренков В.И., Шапран М.В. Уреаплазменная инфекция: современное состояние чувствительности и резистентности к антибиотикам. Вестн. дерматол. и венерол. 2006; (2): 59-61.

RIGHTS & PERMISSIONS

Aliev N.N., Zeynalov M.S., Alieva N.N.